WuXi PharmaTech (WX) Tops Q1 EPS by 1c; Guides Q2 Sales

May 10, 2012 4:33 PM EDT Send to a Friend
WuXi PharmaTech (NYSE: WX) reported Q1 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $118 million versus the consensus estimate of $114.19 million.

Sees Q2 2012 revenue of $124-$129 million, versus the consensus of $118.03 million.

For earnings history and earnings-related data on WuXi PharmaTech (WX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment